Y-Intercept (HK)’s Acceleron Pharma XLRN Stock Holding History

Y-Intercept (HK)’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,683	Closed	-$462K	–	962
2021 Q3	$462K	Buy	+2,683	New	+$351K	0.08%	350
2021 Q1	–	Sell	-2,970	Closed	-$380K	–	886
2020 Q4	$380K	Buy	+2,970	New	+$348K	0.16%	234

Y-Intercept (HK)'s XLRN Position: Q4 2021 in Review

Y-Intercept (HK) sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 2,683 shares — an estimated $462K sold.

Y-Intercept (HK) first reported a position in XLRN in Q4 2020 and held it in 2 quarters. The position peaked at $462K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Y-Intercept (HK) reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Y-Intercept (HK) sold 2,683 Acceleron Pharma shares in Q4 2021, an estimated $462K.
Y-Intercept (HK) first reported a position in Acceleron Pharma in Q4 2020 and held it in 2 quarters.
Y-Intercept (HK)'s Acceleron Pharma position peaked at $462K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Y-Intercept (HK)'s 13F filing for Q4 2021, filed 14 Feb 2022.